Grove Bank & Trust Teva Pharmaceutical Industries LTD Transaction History
Grove Bank & Trust
- $843 Million
- Q3 2025
A detailed history of Grove Bank & Trust transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Grove Bank & Trust holds 250 shares of TEVA stock, worth $6,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250Holding current value
$6,352% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
670Shares Held
624MCall Options Held
30.8MPut Options Held
18.5M-
Black Rock Inc. New York, NY43MShares$1.09 Billion0.02% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L341.3MShares$1.05 Billion10.51% of portfolio
-
Menora Mivtachim Holdings Ltd.38.9MShares$989 Million4.08% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.37.7MShares$958 Million6.84% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.32.6MShares$828 Million7.09% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $28.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...